Predicting oral absorption and bioavailability.

Publisher Summary The prediction of oral absorption and bioavailability is an important tool, both in the early phases of drug discovery to select the most promising leads for further optimization and in the later stages to select candidates for clinical development. Progress in predicting oral absorption is based on a much better understanding of the transport processes across membranes. The identification of the key physico-chemical properties, and in addition, the identification of the key transporter proteins and metabolizing enzymes in the gut wall, has led to the development of in vitro and in vivo screens that allow reasonably accurate estimates of oral absorption in man to be made. Predicting bioavailability is more challenging. However, in recent years, very promising progress has been made using a combination of several in vitro measures, as well as the development of in silico tools.

[1]  M. Boisset,et al.  Absorption of angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo: importance of drug ionisation in the in vitro prediction of in vivo absorption. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  Michael Wiese,et al.  Drug-membrane interactions : analysis, drug distribution, modeling , 2002 .

[3]  Y Zhang,et al.  The Gut as a Barrier to Drug Absorption , 2001, Clinical pharmacokinetics.

[4]  M. Abraham,et al.  On the partition of ampholytes: application to blood-brain distribution. , 1997, Journal of pharmaceutical sciences.

[5]  Malcolm Rowland,et al.  Comparison of HT29-18-C1 and Caco-2 Cell Lines as Models for Studying Intestinal Paracellular Drug Absorption , 1996, Pharmaceutical Research.

[6]  A. Eckert,et al.  Solid-supported lipid membranes as a tool for determination of membrane affinity: high-throughput screening of a physicochemical parameter. , 2001, Journal of pharmaceutical sciences.

[7]  Gordon M. Crippen,et al.  Prediction of Physicochemical Parameters by Atomic Contributions , 1999, J. Chem. Inf. Comput. Sci..

[8]  Bernard Testa,et al.  Intermolecular Forces Expressed in 1,2-Dichloroethane/Water Partition Coefficients: A Solvatochromic Analysis , 1997 .

[9]  A. Avdeef,et al.  pH-metric log P. II: Refinement of partition coefficients and ionization constants of multiprotic substances. , 1993, Journal of pharmaceutical sciences.

[10]  D. Massart,et al.  Quantitative structure-retention and retention-activity relationships of beta-blocking agents by micellar liquid chromatography. , 2001, Journal of chromatography. A.

[11]  U Norinder,et al.  Theoretical calculation and prediction of P-glycoprotein-interacting drugs using MolSurf parametrization and PLS statistics. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  C. Bevan,et al.  A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. , 2000, Analytical chemistry.

[13]  M. Yazdanian,et al.  Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds , 1998, Pharmaceutical Research.

[14]  K. Iseki,et al.  A general approach for the prediction of the intestinal absorption of drugs: regression analysis using the physicochemical properties and drug-membrane electrostatic interaction. , 1998, Journal of pharmaceutical sciences.

[15]  I. Schoots,et al.  Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats. , 2001, Molecular pharmacology.

[16]  K. Luthman,et al.  Virtual screening of intestinal drug permeability. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Gianpaolo Bravi,et al.  Application of MS-WHIM Descriptors: 3. Prediction of Molecular Properties , 2000 .

[18]  I Moriguchi,et al.  Non-congeneric structure-pharmacokinetic property correlation studies using fuzzy adaptive least-squares: oral bioavailability. , 1994, Biological & pharmaceutical bulletin.

[19]  P. Arnaud,et al.  HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. , 2001, Journal of pharmaceutical sciences.

[20]  Arun K Mandagere,et al.  Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates. , 2002, Journal of medicinal chemistry.

[21]  L. Benet,et al.  Active secretion and enterocytic drug metabolism barriers to drug absorption 1 PII of original artic , 1996 .

[22]  M. Fromm,et al.  Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin , 1996, Hepatology.

[23]  K. Luthman,et al.  Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. , 1999, The Journal of pharmacology and experimental therapeutics.

[24]  J. D. Elliott,et al.  Prediction of the Intestinal Absorption of Endothelin Receptor Antagonists Using Three Theoretical Methods of Increasing Complexity , 1999, Pharmaceutical Research.

[25]  Shiyin Yee,et al.  In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.

[26]  Ruifeng Liu,et al.  Development of Quantitative Structure-Property Relationship Models for Early ADME Evaluation in Drug Discovery. 1. Aqueous Solubility , 2001, J. Chem. Inf. Comput. Sci..

[27]  C. Kibbey,et al.  An integrated process for measuring the physicochemical properties of drug candidates in a preclinical discovery environment. , 2001, Journal of pharmaceutical sciences.

[28]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[29]  R. Walgren,et al.  The Influence of Plasma Binding on Absorption/Exsorption in the Caco‐2 Model of Human Intestinal Absorption , 1999, The Journal of pharmacy and pharmacology.

[30]  R. Obach,et al.  The prediction of human clearance from hepatic microsomal metabolism data. , 2001, Current opinion in drug discovery & development.

[31]  M. Abraham,et al.  The correlation and prediction of the solubility of compounds in water using an amended solvation energy relationship. , 1999, Journal of pharmaceutical sciences.

[32]  A. Seelig A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.

[33]  H. Melhus,et al.  Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. , 2001, The Journal of pharmacology and experimental therapeutics.

[34]  Han van de Waterbeemd,et al.  High-throughput and in silico techniques in drug metabolism and pharmacokinetics. , 2002 .

[35]  R. Conradi,et al.  The Influence of Peptide Structure on Transport Across Caco-2 Cells , 1991, Pharmaceutical Research.

[36]  J J Baldwin,et al.  Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.

[37]  Han van de Waterbeemd,et al.  Estimation of Caco‐2 Cell Permeability using Calculated Molecular Descriptors , 1996 .

[38]  Denis M. Bayada,et al.  Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs , 1999, Pharmaceutical Research.

[39]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[40]  W. H. Barr,et al.  Intestinal drug absorption and metabolism. I. Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorption. , 1970, Journal of pharmaceutical sciences.

[41]  Kristina Luthman,et al.  Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.

[42]  H vandeWaterbeemd,et al.  The fundamental variables of the biopharmaceutics classification system (BCS): a commentary. , 1998 .

[43]  O. H. Chan,et al.  Evaluation of physicochemical parameters important to the oral bioavailability of peptide-like compounds: implications for the synthesis of renin inhibitors. , 1995, Journal of medicinal chemistry.

[44]  U Norinder,et al.  Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.

[45]  H. Lennernäs,et al.  Regional Rectal Perfusion: A New in Vivo Approach to Study Rectal Drug Absorption in Man , 2004, Pharmaceutical Research.

[46]  A. Seelig,et al.  Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison. , 2000, International journal of clinical pharmacology and therapeutics.

[47]  Markus Wagener,et al.  Potential Drugs and Nondrugs: Prediction and Identification of Important Structural Features , 2000, J. Chem. Inf. Comput. Sci..

[48]  Martyn G. Ford,et al.  Simultaneous prediction of aqueous solubility and octanol/water partition coefficient based on descriptors derived from molecular structure , 2001, J. Comput. Aided Mol. Des..

[49]  A. Avdeef,et al.  pH-metric solubility. 3. Dissolution titration template method for solubility determination. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[50]  S. Ekins,et al.  Three-dimensional quantitative structure activity relationship computational approaches for prediction of human in vitro intrinsic clearance. , 2000, The Journal of pharmacology and experimental therapeutics.

[51]  R. Fontana,et al.  Molecular and physical mechanisms of first-pass extraction. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[52]  S. Anzali,et al.  Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS). , 2001, Journal of medicinal chemistry.

[53]  Gilles Klopman,et al.  META. 1. A Program for the Evaluation of Metabolic Transformation of Chemicals , 1994, J. Chem. Inf. Comput. Sci..

[54]  Ajay,et al.  Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.

[55]  H. Girault,et al.  Structure-Lipophilicity Relationships of Neutral and Protonated β-Blockers, Part I, Intra- and Intermolecular Effects in Isotropic Solvent Systems , 1999 .

[56]  G Benoni,et al.  Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model. , 2001, Journal of pharmaceutical sciences.

[57]  P Langguth,et al.  Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein. , 1999, Journal of pharmaceutical sciences.

[58]  Lawrence X. Yu,et al.  Predicting Human Oral Bioavailability of a Compound: Development of a Novel Quantitative Structure-Bioavailability Relationship , 2000, Pharmaceutical Research.

[59]  H Matter,et al.  Computational approaches towards the rational design of drug-like compound libraries. , 2001, Combinatorial chemistry & high throughput screening.

[60]  U Norinder,et al.  Prediction of drug transport processes using simple parameters and PLS statistics. The use of ACD/logP and ACD/ChemSketch descriptors. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[61]  Improved Prediction of In Vivo Peroral Absorption from In Vitro Intestinal Permeability Using an Internal Standard to Control for Intra- and Inter-Rat Variability , 1997, Pharmaceutical Research.

[62]  C. Pidgeon,et al.  Immobilized Artificial Membranes — screens for drug membrane interactions , 1997 .

[63]  D. Shen,et al.  Oral first‐pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A‐mediated metabolism , 1996, Clinical pharmacology and therapeutics.

[64]  A. Seelig,et al.  Structure-activity relationship of P-glycoprotein substrates and modifiers. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[65]  H. Chow A physiologically based pharmacokinetic model of zidovudine (AZT) in the mouse: model development and scale-up to humans. , 1997, Journal of pharmaceutical sciences.

[66]  P N Judson,et al.  Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. , 1999, SAR and QSAR in environmental research.

[67]  Tudor I. Oprea,et al.  Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..

[68]  G Folkers,et al.  Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[69]  K Gubernator,et al.  Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. , 1998, Journal of medicinal chemistry.

[70]  K. Iseki,et al.  Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract. , 2001, International journal of pharmaceutics.

[71]  A. Seelig,et al.  Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion , 1998, The Journal of Membrane Biology.

[72]  Chao-pin Lee,et al.  Chemical Approaches to Improve the Oral Bioavailability of Peptidergic Molecules , 1996, The Journal of pharmacy and pharmacology.

[73]  T Lavé,et al.  Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques. , 1999, Journal of medicinal chemistry.

[74]  Gerd Folkers,et al.  Pharmacokinetic optimization in drug research , 2001 .

[75]  B Agoram,et al.  Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.

[76]  Kevin C. Johnson,et al.  Guidance in the Setting of Drug Particle Size Specifications to Minimize Variability in Absorption , 1996, Pharmaceutical Research.

[77]  U. Norinder,et al.  The applicability of computational chemistry in the evaluation and prediction of drug transport properties , 2000 .

[78]  P. Morgan,et al.  Role of transport proteins in drug absorption, distribution and excretion , 2001, Xenobiotica; the fate of foreign compounds in biological systems.

[79]  B. Sarkadi,et al.  Calcein accumulation as a fluorometric functional assay of the multidrug transporter. , 1994, Biochimica et biophysica acta.

[80]  K. Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport , 1996 .

[81]  G Folkers,et al.  Shapes of membrane permeability-lipophilicity curves: extension of theoretical models with an aqueous pore pathway. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[82]  O. H. Chan,et al.  Physicochemical and drug-delivery considerations for oral drug bioavailability , 1996 .

[83]  Ulf Norinder,et al.  Theoretical Calculation and Prediction of Caco-2 Cell Permeability Using MolSurf Parametrization and PLS Statistics , 1997, Pharmaceutical Research.

[84]  Raimund Mannhold,et al.  The hydrophobic fragmental constant approach forcalculating log P in octanol/water and aliphatic hydrocarbon/water systems , 2000 .

[85]  J B Houston,et al.  Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices. , 1997, Drug metabolism reviews.

[86]  D. E. Clark,et al.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.

[87]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[88]  A T Florence,et al.  Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. , 1994, Journal of drug targeting.

[89]  S. Nylander,et al.  Jejunal Permeability: A Comparison Between the Ussing Chamber Technique and the Single-Pass Perfusion in Humans , 1997, Pharmaceutical Research.

[90]  I K Pajeva,et al.  Structure-activity relationships of multidrug resistance reversers. , 2001, Current medicinal chemistry.

[91]  K. Luthman,et al.  Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. , 1998, Journal of medicinal chemistry.

[92]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[93]  R C Chou,et al.  Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. , 1997, Journal of pharmaceutical sciences.

[94]  L. Dittert,et al.  Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates. , 1969, Journal of pharmaceutical sciences.

[95]  C. Pidgeon,et al.  Immobilized-artificial-membrane chromatography: measurements of membrane partition coefficient and predicting drug membrane permeability. , 1996, Journal of chromatography. A.

[96]  P A Carrupt,et al.  Evaluation and Prediction of Drug Permeation , 1999, The Journal of pharmacy and pharmacology.

[97]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[98]  P. Lundahl,et al.  Immobilized liposome chromatography of drugs for model analysis of drug-membrane interactions , 1997 .

[99]  Claude Roques,et al.  Correlation Between Oral Drug Absorption in Humans, and Apparent Drug Permeability in TC-7 Cells, A Human Epithelial Intestinal Cell Line: Comparison with the Parental Caco-2 Cell Line , 1998, Pharmaceutical Research.

[100]  D. Shen,et al.  First‐pass metabolism of midazolam by the human intestine , 1996, Clinical pharmacology and therapeutics.

[101]  H Lennernäs,et al.  Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.

[102]  S. Jezequel Fluconazole: Interspecies Scaling and Allometric Relationships of Pharmacokinetic Properties , 1994, The Journal of pharmacy and pharmacology.

[103]  Bernard Testa,et al.  Polar intermolecular interactions encoded in partition coefficients: an indirect estimation of hydrogen-bond parameters of polyfunctional solutes , 1992 .

[104]  H. Kubinyi,et al.  A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.

[105]  R Griffiths,et al.  Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. , 1988, Journal of medicinal chemistry.

[106]  John G. Topliss,et al.  QSAR Model for Drug Human Oral Bioavailability1 , 2000 .

[107]  Y. Sugiyama,et al.  Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[108]  Y Zhang,et al.  Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. , 1998, Journal of pharmaceutical sciences.

[109]  J. Blake,et al.  Chemoinformatics - predicting the physicochemical properties of 'drug-like' molecules. , 2000, Current opinion in biotechnology.

[110]  I. Muegge,et al.  "Holistic" in silico methods to estimate the systemic and CNS bioavailabilities of potential chemotherapeutic agents. , 2001, Current topics in medicinal chemistry.

[111]  D. Shen,et al.  Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction. , 1997, Advanced drug delivery reviews.

[112]  C. Regårdh,et al.  Pharmacokinetics of felodipine in patients with liver disease , 2004, European Journal of Clinical Pharmacology.

[113]  Caron,et al.  Combined molecular lipophilicity descriptors and their role in understanding intramolecular effects. , 1999, Pharmaceutical science & technology today.

[114]  J. Beijnen,et al.  The pharmacological role of P-glycoprotein in the intestinal epithelium. , 1998, Pharmacological research.

[115]  J. Legendre,et al.  Determination of the passive absorption through the rat intestine using chromatographic indices and molar volume. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[116]  Oleg A. Raevsky,et al.  Quantitative estimation of hydrogen bond contribution to permeability and absorption processes of some chemicals and drugs , 1998 .

[117]  Per Artursson,et al.  Selective Paracellular Permeability in Two Models of Intestinal Absorption: Cultured Monolayers of Human Intestinal Epithelial Cells and Rat Intestinal Segments , 1993, Pharmaceutical Research.

[118]  M. Khaledi,et al.  Congeneric behavior in estimations of octanol-water partition coefficients by micellar electrokinetic chromatography. , 2000, Analytical chemistry.

[119]  M. Zhong,et al.  Medium‐throughput pKa screening of pharmaceuticals by pressure‐assisted capillary electrophoresis , 2001, Electrophoresis.

[120]  P. Darke,et al.  L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[121]  Hébert Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. , 1997, Advanced drug delivery reviews.

[122]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[123]  M. J. Eadie,et al.  The pharmacokinetics of midazolam in man , 2004, European Journal of Clinical Pharmacology.

[124]  Morton B. Brown,et al.  Role of intestinal P‐glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine , 1997, Clinical pharmacology and therapeutics.

[125]  T Ishizaki,et al.  Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. , 1997, Pharmacology & therapeutics.

[126]  K. Marsh,et al.  Azole endothelin antagonists. 3. Using delta log P as a tool to improve absorption. , 1996, Journal of medicinal chemistry.

[127]  A. Watt,et al.  An Increased Throughput Method for the Determination of Partition Coefficients , 2000, Pharmaceutical Research.

[128]  M. Strafford,et al.  Drug absorption in vitro model: filter-immobilized artificial membranes. 2. Studies of the permeability properties of lactones in Piper methysticum Forst. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[129]  Bernard Testa,et al.  Lipophilicity Behavior of Model and Medicinal Compounds containing a suilfide, sulfoxide, or sulfone moiety , 1997 .

[130]  Sean Ekins,et al.  Three-Dimensional Quantitative Structure-Permeability Relationship Analysis for a Series of Inhibitors of Rhinovirus Replication , 2001, J. Chem. Inf. Comput. Sci..

[131]  J. Polli,et al.  Rational use of in vitro P-glycoprotein assays in drug discovery. , 2001, The Journal of pharmacology and experimental therapeutics.

[132]  Han van de Waterbeemd,et al.  Substructure and whole molecule approaches for calculating log P , 2001, J. Comput. Aided Mol. Des..

[133]  L. Mayer,et al.  Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[134]  I. Muegge,et al.  Computational methods to estimate drug development parameters. , 2001, Current opinion in drug discovery & development.

[135]  O. H. Chan,et al.  Comparison of Intestinal Permeabilities Determined in Multiple in Vitro and inSitu Models: Relationship to Absorption in Humans , 1995, Pharmaceutical Research.

[136]  K. Terada,et al.  Optimized conditions of bio-mimetic artificial membrane permeation assay. , 2001, International journal of pharmaceutics.

[137]  Beate I. Escher,et al.  Evaluation of Liposome−Water Partitioning of Organic Acids and Bases. 2. Comparison of Experimental Determination Methods , 2000 .

[138]  Gary O. Spessard,et al.  ACD Labs/LogP dB 3.5 and ChemSketch 3.5 , 1998, J. Chem. Inf. Comput. Sci..

[139]  C. Lipinski Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[140]  Hamish Ryder,et al.  Prediction of Drug Permeability Based on Grid Calculations , 1999 .

[141]  B. Müller,et al.  Drug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption , 1999, Pharmaceutical Research.

[142]  David J. Begley,et al.  Potential of Immobilized Artificial Membranes for Predicting Drug Penetration Across the Blood−Brain Barrier , 1998, Pharmaceutical Research.

[143]  Christos Reppas,et al.  Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.

[144]  E. Kharasch,et al.  Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[145]  Taravat Ghafourian,et al.  Hydrogen Bonding Parameters for QSAR: Comparison of Indicator Variables, Hydrogen Bond Counts, Molecular Orbital and Other Parameters , 1999, J. Chem. Inf. Comput. Sci..

[146]  R. Tauler,et al.  Spectrophotometric determination of pKa values based on a pH gradient flow-injection system , 2000 .

[147]  J. Tolan,et al.  MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.

[148]  Han van de Waterbeemd,et al.  Lipophilicity in drug action and toxicology , 1996 .

[149]  Kristina Luthman,et al.  Prediction of Membrane Permeability to Peptides from Calculated Dynamic Molecular Surface Properties , 1999, Pharmaceutical Research.

[150]  M Rowland,et al.  Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. , 2001, The Journal of pharmacology and experimental therapeutics.

[151]  R. Boucher,et al.  Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. , 1992, The Journal of biological chemistry.

[152]  C. Pidgeon,et al.  Intestinal Peptide Transport Systems and Oral Drug Availability , 1999, Pharmaceutical Research.

[153]  James W. McFarland,et al.  Quantitative Estimation of Drug Absorption in Humans for Passively Transported Compounds on the Basis of Their Physico‐chemical Parameters , 2000 .

[154]  H. van de Waterbeemd,et al.  Property-based design: optimization of drug absorption and pharmacokinetics. , 2001, Journal of medicinal chemistry.

[155]  Pierre Bruneau,et al.  Search for Predictive Generic Model of Aqueous Solubility Using Bayesian Neural Nets , 2001, J. Chem. Inf. Comput. Sci..

[156]  M. Machida,et al.  High Throughput Prediction of Oral Absorption: Improvement of the Composition of the Lipid Solution Used in Parallel Artificial Membrane Permeation Assay , 2001, Journal of biomolecular screening.

[157]  H. Waterbeemd,et al.  Comparison of passive drug transport through Caco-2 cells and artificial membranes , 1997 .

[158]  U Norinder,et al.  Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[159]  G Ecker,et al.  Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements. , 1999, Biochemical pharmacology.

[160]  S Agatonovic-Kustrin,et al.  Theoretically-derived molecular descriptors important in human intestinal absorption. , 2001, Journal of pharmaceutical and biomedical analysis.

[161]  K. Inui,et al.  Effects of Intestinal and Hepatic Metabolism on the Bioavailability of Tacrolimus in Rats , 1998, Pharmaceutical Research.

[162]  R. Borchardt,et al.  A Functional Assay for Quantitation of the Apparent Affinities of Ligands of P-Glycoprotein in Caco-2 Cells , 2001, Pharmaceutical Research.

[163]  Ajay,et al.  Designing libraries with CNS activity. , 1999, Journal of medicinal chemistry.

[164]  James W. McFarland,et al.  Estimating the Water Solubilities of Crystalline Compounds from Their Chemical Structures Alone , 2001, J. Chem. Inf. Comput. Sci..

[165]  S. Yamashita,et al.  A new interpretation of salicylic acid transport across the lipid bilayer: implications of pH-dependent but not carrier-mediated absorption from the gastrointestinal tract. , 1998, The Journal of pharmacology and experimental therapeutics.

[166]  Ulf Norinder,et al.  Prediction of Polar Surface Area and Drug Transport Processes Using Simple Parameters and PLS Statistics , 2000, J. Chem. Inf. Comput. Sci..

[167]  S. Goldstein,et al.  IAM retention and blood brain barrier penetration , 1998 .

[168]  M. Bermejo,et al.  Intrinsic absolute bioavailability prediction in rats based on in situ absorption rate constants and/or in vitro partition coefficients: 6-fluoroquinolones. , 2000, Journal of pharmaceutical sciences.

[169]  B. Müller,et al.  Determination of liposome partitioning of ionizable drugs by titration. , 1999, Journal of pharmaceutical sciences.

[170]  D. Bucher,et al.  Oral Immunization of Rats with Proteinoid Microspheres Encapsulating Influenza Virus Antigens , 1993, Pharmaceutical Research.

[171]  O. H. Chan,et al.  Use of immobilized artificial membrane chromatography for drug transport applications. , 1998, Journal of pharmaceutical sciences.

[172]  H Lennernäs,et al.  SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans. , 2000, Journal of medicinal chemistry.

[173]  H H USSING,et al.  Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. , 1951, Acta physiologica Scandinavica.

[174]  A. Avdeef,et al.  pH-Metric logP 10. Determination of Liposomal Membrane-Water Partition Coefficients of lonizable Drugs , 1998, Pharmaceutical Research.

[175]  I Mahmood,et al.  Allometric issues in drug development. , 1999, Journal of pharmaceutical sciences.

[176]  Human P‐Glycoprotein Pseudoreceptor Modeling: 3D‐QSAR Study on Thioxanthene Type Multidrug Resistance Modulators , 2001 .

[177]  Y. Sugiyama,et al.  Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[178]  W. J. Irwin,et al.  A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 2: affinities of ACE inhibitors. , 2000, International journal of pharmaceutics.

[179]  J R Chretien,et al.  Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. , 1998, Journal of drug targeting.

[180]  D A Smith,et al.  Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics , 1996, Medicinal research reviews.

[181]  D. E. Clark Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.

[182]  G Folkers,et al.  Review of theoretical passive drug absorption models: historical background, recent developments and limitations. , 1996, Pharmaceutica acta Helvetiae.

[183]  Akira Tsuji,et al.  Carrier-Mediated Intestinal Transport of Drugs , 1996, Pharmaceutical Research.

[184]  J. Huuskonen,et al.  Estimation of aqueous solubility in drug design. , 2001, Combinatorial chemistry & high throughput screening.

[185]  G Beck,et al.  Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.

[186]  Peter C. Jurs,et al.  Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..

[187]  M. Bermejo,et al.  Validation of a biophysical drug absorption model by the PATQSAR system. , 1999, Journal of pharmaceutical sciences.

[188]  Shiew-Mei Huang,et al.  Effects of Structural Modifications on the Intestinal Permeability of Angiotensin II Receptor Antagonists and the Correlation of In Vitro, In Situ, and In Vivo Absorption , 1996, Pharmaceutical Research.

[189]  Inman Harvey,et al.  Evolutionary computational methods to predict oral bioavailability QSPRs. , 2002, Current opinion in drug discovery & development.

[190]  H. Yuasa,et al.  Comparative Assessment of D‐Xylose Absorption between Small Intestine and Large Intestine , 1997, The Journal of pharmacy and pharmacology.

[191]  A. Ghose,et al.  A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.

[192]  D. Smith,et al.  Species differences in metabolism and pharmacokinetics: are we close to an understanding? , 1991, Drug metabolism reviews.

[193]  J. Robert,et al.  Multidrug resistance reversal agents. , 2003, Journal of medicinal chemistry.

[194]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[195]  I. Pastan,et al.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.

[196]  Albert J. Leo,et al.  Calculating log P(oct) with no missing fragments; The problem of estimating new interaction parameters , 2000 .

[197]  P Buchwald,et al.  Octanol-water partition: searching for predictive models. , 1998, Current medicinal chemistry.

[198]  R E White,et al.  Pharmacokinetic theory of cassette dosing in drug discovery screening. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[199]  G. Amidon,et al.  Drug transport and targeting. Intestinal transport. , 1999, Pharmaceutical biotechnology.

[200]  P. Stocker,et al.  Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expression. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[201]  M. A. Moseley,et al.  CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[202]  U. Christians,et al.  Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine. , 1998, The Journal of pharmacology and experimental therapeutics.

[203]  B. Faller,et al.  High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. , 2001, Journal of medicinal chemistry.

[204]  L. Escuder-Gilabert,et al.  Biopartitioning micellar chromatography: an in vitro technique for predicting human drug absorption. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[205]  P. Carrupt,et al.  Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .

[206]  C. Beglinger,et al.  Relevance of p‐glycoprotein for the enteral absorption of cyclosporin A: in vitro‐in vivo correlation , 1996, British journal of pharmacology.

[207]  M K Bayliss,et al.  High-throughput pharmacokinetics: cassette dosing. , 1999, Current opinion in drug discovery & development.